Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
BioDlink International (1875 HK)
Watchlist
74
Analysis
Health Care
•
China
Develops, manufactures and markets anti-tumor drugs
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Toyota Industries
•
25 Jan 2026 06:15
Asia-Pac M&A Weekly Wrap: Australian Strategic Materials, Qube, Dongfeng Motor, Raksul, IJM Corp
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
309 Views
Share
bearish
•
Wuxi Biologics
•
19 Jan 2026 11:09
StubWorld: WuXi Biologics (2269 HK)'s Double Discounts; Melco (200 HK) Further Out Of Whack
WuXi XDC Cayman (2268 HK)'s Offer for BioDlink International (1875 HK) will add an additional discount layer to WuXi Biologics (2269 HK). Plus...
David Blennerhassett
Follow
551 Views
Share
bullish
•
WuXi XDC
•
19 Jan 2026 08:55
WuXi XDC (2268 HK) To Acquire BioDlink (1875 HK) - A Done Deal; A New ADC Overlord Will Emerge
WuXi XDC's acquisition of BioDlink at HK$4.00/share is seen as a done deal, with potential for growth and synergy effects in 2025-2027. WuXi XDC...
Xinyao (Criss) Wang
Follow
705 Views
Share
bullish
•
Ijm Corp Bhd
•
19 Jan 2026 02:17
Merger Arb Mondays (19 Jan) - IJM, Dongfeng, BioDlink, Makino, Toyota Ind, Mandom, Qube, Webjet
I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
619 Views
Share
bullish
•
Toyota Industries
•
18 Jan 2026 07:22
Weekly Deals Digest (18 Jan) - Toyota Ind, Mandom, IJM, BioDlink, Dongfeng, Qube, Montage, Busy Ming
A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
Arun George
Follow
323 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x